0.1319
price down icon7.11%   -0.0101
after-market Dopo l'orario di chiusura: .13 -0.0019 -1.44%
loading

Aspire Biopharma Holdings Inc Borsa (ASBP) Ultime notizie

pulisher
Dec 31, 2025

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements - South Bend Tribune

Dec 31, 2025
pulisher
Dec 30, 2025

Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack) - Livingston Daily

Dec 30, 2025
pulisher
Dec 28, 2025

Aspire Biopharma Provides Q3 2025 Business Update - Montgomery Advertiser

Dec 28, 2025
pulisher
Dec 27, 2025

Aspire Biopharma Holdings, Inc. Announces CEO Transition - aberdeennews.com

Dec 27, 2025
pulisher
Dec 27, 2025

Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member - Petoskey News-Review

Dec 27, 2025
pulisher
Dec 27, 2025

Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation - Pensacola News Journal

Dec 27, 2025
pulisher
Dec 26, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Dec 26, 2025
pulisher
Dec 23, 2025

Aspire Biopharma Holdings, Inc. Warrant 2025-18.02.30 on Aspire Bio Hldgs Revenue Breakdown – NASDAQ:ASBPW - TradingView — Track All Markets

Dec 23, 2025
pulisher
Dec 23, 2025

Aspire Biopharma Holdings, Inc. Warrant 2025-18.02.30 on Aspire Bio Hldgs - TradingView — Track All Markets

Dec 23, 2025
pulisher
Dec 21, 2025

Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin - Bluffton Today

Dec 21, 2025
pulisher
Dec 20, 2025

Aspire Biopharma Welcomes Elite Ultra-Runner Ashley Paulson as Global Brand Ambassador for BUZZ BOMB(R) Caffeine - The Florida Times-Union

Dec 20, 2025
pulisher
Dec 20, 2025

ASBPAI Stock Analysis - Meyka

Dec 20, 2025
pulisher
Dec 19, 2025

Aspire Biopharma welcomes Ashley Paulson as Brand Ambassador - Comunicaffe International

Dec 19, 2025
pulisher
Dec 18, 2025

Aspire Biopharma Welcomes Elite Ultra-Runner Ashley Paulson as Gl - The National Law Review

Dec 18, 2025
pulisher
Dec 18, 2025

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Dec 18, 2025
pulisher
Dec 18, 2025

Aspire Biopharma names Ashley Paulson BUZZ BOMB global brand ambassador - TipRanks

Dec 18, 2025
pulisher
Dec 15, 2025

Aspire Biopharma Holdings (ASBP) Stock on Dec. 15, 2025: Nasdaq Extension, FDA Pre‑IND Momentum, and Dilution Risks Investors Are Watching - ts2.tech

Dec 15, 2025
pulisher
Dec 13, 2025

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance With Continued Listing Requirements - 富途牛牛

Dec 13, 2025
pulisher
Dec 13, 2025

Aspire Biopharma Hldgs (ASBP) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 13, 2025
pulisher
Dec 12, 2025

Aspire Biopharma gets Nasdaq extension to meet listing requirements By Investing.com - Investing.com Nigeria

Dec 12, 2025
pulisher
Dec 12, 2025

Aspire Biopharma gets Nasdaq extension to meet listing requirements - Investing.com

Dec 12, 2025
$38.64
price down icon 0.90%
$30.80
price down icon 2.19%
$98.77
price down icon 0.14%
$95.20
price down icon 0.08%
biotechnology ONC
$303.81
price down icon 0.30%
$174.04
price down icon 0.03%
Capitalizzazione:     |  Volume (24 ore):